Leiden, the Netherlands, April 23, 2026: Pharming Staff N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it’s going to record its initial (unaudited) monetary effects for the primary quarter 2026 and supply a industry replace on Thursday, Might 7, 2026.
Control will host a convention name and webcast for analysts and traders at the similar day at 13:30 CEST/07:30 am EDT.
To take part within the convention name or to look at the reside webcast, please check in prematurely the use of the hyperlinks beneath.
Convention name registration:https://register-conf.media-server.com/check in/BI1dba0cdf00fd47289729b51369140831
As soon as registered, dial-in data and a novel PIN shall be equipped, permitting get entry to to the decision.
Please notice, the Corporate will most effective take questions from dial-in attendees.
Webcast registration: https://edge.media-server.com/mmc/p/topu6hc2/
The webcast can be obtainable at the Pharming web page at Buyers/Monetary Paperwork, and a replay shall be to be had in a while after the development.
About Pharming Staff N.V.Pharming Staff N.V. (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) is an international biopharmaceutical corporate devoted to remodeling the lives of sufferers with uncommon, debilitating, and life-threatening illnesses. We increase and commercialize leading edge medications, together with small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with U.S. and Ecu operations.
For more info, seek advice from www.pharming.com and in finding us on LinkedIn.
Netherlands: Leon Melens (LifeSpring Existence Sciences Communique on behalf of Pharming)T: +31 6 53 81 64 27
Pharming Staff to record 1Q26 results_EN_23APR26
